Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin

Cancer Chemotherapy and Pharmacology

Volumn 68, Issue 3, 2011, Pages 693-701

  Holweger, Karin ^a   Lipp, Hans Peter ^a   Beijnen, Jos H ^b   Bokemeyer, Carsten ^c   Hartmann, Joerg Thomas ^d  

^a Department of Hospital Pharmacy ^*  (Germany)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

Carboplatin AUC; Cystatin C; Glomerular filtration rate; Novel algorithm

Indexed keywords

CARBOPLATIN; CYSTATIN C; ETOPOSIDE; GEMCITABINE; NAVELBINE; PACLITAXEL; PEMETREXED; TRASTUZUMAB;

ADULT; ALGORITHM; AREA UNDER THE CURVE; ARTICLE; CALCULATION; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MALE; OBESITY; PRIORITY JOURNAL;

AGED; ALGORITHMS; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; BLOOD UREA NITROGEN; BODY MASS INDEX; CARBOPLATIN; CREATININE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NEOPLASMS; OBESITY; RENAL INSUFFICIENCY; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN;

EID: 80054701317     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-010-1537-0     Document Type: Article

References (34)

1. AH Calvert SJ Harland DR Newell ZH Siddik AC Jones TJ McElwain S Raju E Wiltshaw IE Smith JM Baker MJ Peckham KR Harrap 1982 Early clinical studies with cis-diammine-1, 1-cyclobutane dicarboxylate platinum II Cancer Chemother Pharmacol 9 140 147 6761010 10.1007/BF00257742 1:STN:280:DyaL3s7ivFyisg%3D%3D
2. MJ Egorin DA Van Echo SJ Tipping EA Olman MY Whitacre BW Thompson J Aisner 1984 Pharmacokinetics and dosage reduction of cis-diammine(1, 1-cyclobutanedicarboxylato)platinum in patients with impaired renal function Cancer Res 44 5432 5438 6386150 1:STN:280:DyaL2M%2FisVKhsg%3D%3D
3. DI Jodrell MJ Egorin RM Canetta P Langenberg EP Goldbloom JN Burroughs JL Goodlow S Tan E Wiltshaw 1992 Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer J Clin Oncol 10 520 528 1548516 1:STN:280:DyaK387ptl2mug%3D%3D
4. LM Reyno MJ Egorin RM Canetta DI Jodrell KD Swenerton JL Pater JN Burroughs MJ Novak R Sridhara 1993 Impact of cyclophosphamide on relationships between carboplatin exposure and response or toxicity when used in the treatment of advanced ovarian cancer J Clin Oncol 11 1156 1164 8501502 1:STN:280:DyaK3s3nsVensQ%3D%3D
5. AH Calvert DR Newell LA Gumbrell S O'Reilly M Burnell FE Boxall ZH Siddik IR Judson ME Gore E Wiltshaw 1989 Carboplatin dosage: prospective evaluation of a simple formula based on renal function J Clin Oncol 7 1748 1756 2681557 1:STN:280:DyaK3c%2FjvFCmug%3D%3D
6. AH Calvert A Boddy NP Bailey N Siddiqui A Humphreys A Hughes L Robson L Gumbrell H Thomas F Chapman 1995 Carboplatin in combination with paclitaxel in advanced ovarian cancer: dose determination and pharmacokinetic and pharmacodynamic interactions Semin Oncol 22 91 98 7481870 1:CAS:528:DyaK28XjtVal
7. GM Marx GM Blake E Galani CB Steer SE Harper KL Adamson DL Bailey PG Harper 2004 Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients Ann Oncol 15 291 295 14760124 10.1093/annonc/mdh079 1:STN:280:DC%2BD2c%2FlvVamuw%3D%3D
8. SG Poole MJ Dooley D Rischin 2002 A comparison of bedside renal function estimates and measured glomerular filtration rate (Tc99mDTPA clearance) in cancer patients Ann Oncol 13 949 955 12123341 10.1093/annonc/mdf236 1:STN:280:DC%2BD38znslKkuw%3D%3D
9. DW Cockcroft MH Gault 1976 Prediction of creatinine clearance from serum creatinine Nephron 16 31 41 1244564 10.1159/000180580 1:STN:280: DyaE28%2FnsF2isw%3D%3D
10. RW Jelliffe 1973 Letter: Creatinine clearance: bedside estimate Ann Intern Med 79 604 605 4748282 1:STN:280:DyaE2c%2FitFWlug%3D%3D
11. AS Levey JP Bosch JB Lewis T Greene N Rogers D Roth 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 461 470 10075613 1:CAS:528:DyaK1MXitFChs7k%3D
12. DE Salazar GB Corcoran 1988 Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass Am J Med 84 1053 1060 3376975 10.1016/0002-9343(88)90310-5 1:STN:280:DyaL1c3jvVKjug%3D%3D
13. JG Wright AV Boddy M Highley J Fenwick A McGill AH Calvert 2001 Estimation of glomerular filtration rate in cancer patients Br J Cancer 84 452 459 11207037 10.1054/bjoc.2000.1643 1:CAS:528:DC%2BD3MXhvVartbo%3D
14. K Holweger HP Lipp K Dietz JT Hartmann C Bokemeyer 2008 Novel algorithm for more accurate calculation of renal function in adults with cancer Ann Pharmacother 42 1749 1757 19033483 10.1345/aph.1L216 1:CAS:528: DC%2BD1MXmtVekuw%3D%3D
15. FJ Hoek FA Kemperman RT Krediet 2003 A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate Nephrol Dial Transplant 18 2024 2031 13679476 10.1093/ndt/gfg349 1:CAS:528:DC%2BD3sXosF2mu7k%3D
16. A Schmitt L Gladieff A Lansiaux C Bobin-Dubigeon MC Etienne-Grimaldi M Boisdron-Celle F Serre-Debauvais F Pinguet A Floquet E Billaud C Le Guellec N Penel M Campone R Largillier O Capitain M Fabbro N Houede J Medioni P Bougnoux I Lochon E Chatelut 2009 A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients Clin Cancer Res 15 3633 3639 19401344 10.1158/1078-0432.CCR-09-0017 1:CAS:528:DC%2BD1MXmtVKlsL4%3D
17. BT Sorensen A Stromgren P Jakobsen A Jakobsen 1993 A limited sampling method for estimation of the carboplatin area under the curve Cancer Chemother Pharmacol 31 324 327 8422698 10.1007/BF00685679 1:STN:280:DyaK3s7jslCjtA%3D%3D
18. LJC van Warmerdam O van Tellingen RAA Maes JH Beijnen 1995 Validated method for the determination of carboplatin in biological fluids by Zeeman atomic absorption spectrometry Fresenius J Anal Chem 351 777 781 10.1007/BF00323635
19. BD Du EF Du Bois 1919 A formula to estimate the approximate surface area if height and weight be known. 1916 Nutrition 5 303 311
20. E Chatelut A Dezeuze M Lavit C Chevreau A Pujol A Boneu H Roche G Houin R Bugat P Canal 1995 Prediction of carboplatin clearance from morphological and biological patient characteristics Bull Cancer 82 946 953 8535021 1:STN:280:DyaK287ktVCqtw%3D%3D
21. RD Perrone NE Madias AS Levey 1992 Serum creatinine as an index of renal function: new insights into old concepts Clin Chem 38 1933 1953 1394976 1:CAS:528:DyaK38XmsV2htLs%3D
22. RM Corcoran SM Durnan 1977 Albumin determination by a modified bromcresol green method Clin Chem 23 765 766 844180 1:CAS:528:DyaE2sXhvVGgu7o%3D
23. H Finney DJ Newman W Gruber P Merle CP Price 1997 Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II) Clin Chem 43 1016 1022 9191555 1:CAS:528:DyaK2sXjslyiu7g%3D
24. JM Bland DG Altman 1986 Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 307 310 2868172 10.1016/S0140-6736(86)90837-8 1:STN:280:DyaL287hslWqsQ%3D%3D
25. SM Lichtman H Wildiers V Launay-Vacher C Steer E Chatelut M Aapro 2007 International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency Eur J Cancer 43 14 34 17222747 10.1016/j.ejca.2006.11.004
26. V Launay-Vacher S Oudard N Janus J Gligorov X Pourrat O Rixe JF Morere P Beuzeboc G Deray 2007 Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study Cancer 110 1376 1384 17634949 10.1002/cncr.22904 1:CAS:528:DC%2BD2sXhtFCgtr%2FK
27. LA Stevens J Coresh T Greene AS Levey 2006 Assessing kidney function-measured and estimated glomerular filtration rate N Engl J Med 354 2473 2483 16760447 10.1056/NEJMra054415 1:CAS:528:DC%2BD28XlsVaiurk%3D
28. K Holweger C Bokemeyer HP Lipp 2005 Accurate measurement of individual glomerular filtration rate in cancer patients: an ongoing challenge J Cancer Res Clin Oncol 131 559 567 16012866 10.1007/s00432-005-0679-7
29. MJ Dooley SG Poole D Rischin LK Webster 2002 Carboplatin dosing: gender bias and inaccurate estimates of glomerular filtration rate Eur J Cancer 38 44 51 11750838 10.1016/S0959-8049(00)00455-X 1:CAS:528:DC%2BD3MXpt1ait78%3D
30. C Ekhart E de Jonge Milly DR Huitema Alwin JHM Schellens S Rodenhuis H Beijnen Jos 2006 Flat dosing of carboplatin is justified in adult patients with normal renal function Clin Cancer Res 12 6502 6508 17085665 10.1158/1078-0432. CCR-05-1076 1:CAS:528:DC%2BD28XhtFKitbrK
31. PB Bookstaver JW Johnson TP McCoy D Stewart JC Williamson 2008 Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination Ann Pharmacother 42 1758 1765 19047358 10.1345/aph.1L144 1:CAS:528:DC%2BD1MXmtVersg%3D%3D
32. J Kos B Stabuc N Cimerman N Brunner 1998 Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression Clin Chem 44 2556 2557 9836733 1:CAS:528:DyaK1cXotVartLw%3D
33. DW Louvar TB Rogers RF Bailey AJ Matas HN Ibrahim 2007 Cystatin C is not superior to creatinine-based models in estimating glomerular filtration rate in former kidney donors Transplantation 84 1112 1117 17998865 10.1097/01.tp. 0000287128.31773.2c
34. C Donadio A Lucchesi M Ardini S Cosio A Fanucchi A Gadducci 2009 Dose individualization can minimize nephrotoxicity due to carboplatin therapy in patients with ovarian cancer Ther Drug Monit 31 63 69 19077927 10.1097/FTD.0b013e3181947812 1:CAS:528:DC%2BD1MXpt1CjsQ%3D%3D